Get informed when a big investor buys or sells
+ FollowOvervalued by 111.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.60 Billion |
|---|---|
| Enterprise Value | $2.60 Billion |
| Earnings per Share | $-0.19 |
| Beta | 0.52 |
| Outstanding Shares | 126,048,000 |
| P/E Ratio | -88.76 |
|---|---|
| PEG | 47.56 |
| Price to Sales | 10.31 |
| Price to Book Ratio | 4.12 |
| Enterprise Value to Revenue | 8.06 |
| Enterprise Value to EBIT | -79.69 |
| Enterprise Value to Net Income | -89 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.13 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Jiangsu Apon Medical Technology Co., Ltd. operates within China, specializing in the development, manufacturing, and distribution of various medical devices. Its main offerings include microcomputer and disposable injection pumps, wirele...